SOLX® is a Glaucoma device company with a portfolio of products related to reducing, managing and measuring Intraocular Pressure (IOP) in the human eye. The Company’s first product (TiSapphire 790nm Laser) has completed trials and has received FDA clearance. The Company’s second product, a Gold Shunt, is enrolling patients under an IDE. In development is an implantable IOP sensor that is being developed in partnership with Purdue University. The Company’s website (www.SOLX.com) has substantial information related to the status of the trials, recent news and product attributes.
Looking for a particular SOLX employee's phone or email?
The SOLX annual revenue was $1 million in 2026.
1 people are employed at SOLX.
SOLX is based in Waltham, Massachusetts.
The NAICS codes for SOLX are [3333, 333314, 33331, 33, 333].
The SIC codes for SOLX are [38, 382].